Insulin-like growth factor inhibits vascular contraction to 5-hydroxytryptamine: Involvement of tyrosine phosphatase

Citation
A. Melis et al., Insulin-like growth factor inhibits vascular contraction to 5-hydroxytryptamine: Involvement of tyrosine phosphatase, GEN PH-VASC, 34(2), 2000, pp. 137-145
Citations number
33
Categorie Soggetti
Pharmacology & Toxicology
Journal title
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM
ISSN journal
03063623 → ACNP
Volume
34
Issue
2
Year of publication
2000
Pages
137 - 145
Database
ISI
SICI code
0306-3623(200002)34:2<137:IGFIVC>2.0.ZU;2-V
Abstract
This study tests the hypothesis that insulin-like growth factor 1 (IGF-1)-i nduced vasodilation is due to the stimulation of tyrosine phosphatase. Rat aortic segments (endothelium intact) were placed in muscle baths for force measurement. Segments were contracted to serotonin [5-hydroxytyptamine (5-H T), 10(-7)10(-5) M] before and after incubation with IGF-1 (10-100 nM; 90 m in). IGF-1 caused a 20% inhibition of 5-HT-induced contractions. This inhib ition was reversed by the tyrosine phosphatase inhibitors sodium orthovanad ate and molybdate, Orthovanadate did not alter inhibitory properties of the calcium channel antagonist verapamil, suggesting that the phosphatase inhi bitors were relatively specific. IGF-1-induced inhibition was not altered b y blockade of nitric oxide synthase. Western blot analysis confirmed that t he 5-HT-induced stimulation of tyrosine phosphorylation of the 42-kDa extra cellular signal-regulated mitogen-activated protein kinase protein was redu ced by IGF-1 (52% inhibition), an inhibition that was attenuated by orthova nadate. These data are consistent with the hypothesis that the vasodilator activity of IGF-1 is mediated by the activation of a tyrosine phosphatase. (C) 2000 Elsevier Science Inc. All rights reserved.